COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 64 of 403 for:    CLARITHROMYCIN

The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00121550
Recruitment Status : Completed
First Posted : July 21, 2005
Last Update Posted : August 11, 2016
Danish Heart Foundation
Copenhagen Hospital Corporation
The Danish Medical Research Council
The 1991 Pharmacy Foundation
Information provided by (Responsible Party):
Christian Gluud, Copenhagen Trial Unit, Center for Clinical Intervention Research

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2000
Actual Study Completion Date : September 2002
Publications of Results:
Other Publications:
Hansen S, Als-Nielsen B, Damgaard M, Helø OH, Petersen L, Jespersen CM. Intervention with clarithromycin in patients with stable coronary heart disease. The CLARICOR Trial Design. Heart Drug 2001;1:14-9.

Publications automatically indexed to this study by Identifier (NCT Number):